Work

Supplementary Figure 2 from Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 48K, Inhibiting IRAK-1/-4 abrogates the effects of TLR1-TLR2 agonist in melanoma cells
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4362009293
Cites:
Cited by:
Related to: 10